A meta-analysis confirmed that genetic susceptibility to IgAV/HSP is associated with HLA-DRB1*01 and HLA-DRB1*07 variants and suggested that IgAV may be an HLA class II disease (92). This evidence concerns the gene HLA-DRB1 and hereditary spastic paraplegia.